• Go to navigation
  • Go to content
SEROQUEL (quetiapine)

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com
  • Home

Main navigation

  • Home
  • SEROQUEL and SEROQUEL XR Prescribing information
  • SEROQUEL Mode of Action
  • SEROQUEL XR in schizophrenia
  • SEROQUEL in Schizophrenia
    • Efficacy
    • Most common adverse drug reactions
    • Special warnings and precautions for use
    • References
  • SEROQUEL in bipolar mania
  • Key publications
  • Assessment tools
  • SEROQUEL Information for patients
  • SEROQUEL XR Information for patients
  • Resources
  • About AstraZeneca
  • Sitemap

You are here

  • Home
  • SEROQUEL in Schizophrenia

SEROQUEL (quetiapine) is an appropriate choice in the treatment of schizophrenia because:

  • SEROQUEL works to control activation and hostility in schizophrenia1
  • SEROQUEL is effective at improving the positive and negative symptoms of schizophrenia2,3
  • SEROQUEL calms symptoms of anxiety and depression in patients with schizophrenia4
  • SEROQUEL has a well-established tolerability profile5-7


 

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010